1-3 of 3
Johan Lennartsson
Close
Sort by
Journal Articles

IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G 2 /M-phase accumulation and apoptosis in multiple myeloma cells

Thomas Strömberg, Simon Ekman, Leonard Girnita, Lina Y. Dimberg, Olle Larsson, Magnus Axelson, Johan Lennartsson, Ulf Hellman, Kristina Carlson, Anders Österborg, Karin Vanderkerken, Kenneth Nilsson, Helena Jernberg-Wiklund
Journal: Blood
Blood (2006) 107 (2): 669–678.
https://doi.org/10.1182/blood-2005-01-0306
Published: 2006
Includes: Supplemental data
Journal Articles

Stem cell factor promotes mast cell survival via inactivation of FOXO3a-mediated transcriptional induction and MEK-regulated phosphorylation of the proapoptotic protein Bim

Christine Möller, Jessica Alfredsson, Maria Engström, Hanna Wootz, Zou Xiang, Johan Lennartsson, Jan-Ingvar Jönsson, Gunnar Nilsson
Journal: Blood
Blood (2005) 106 (4): 1330–1336.
https://doi.org/10.1182/blood-2004-12-4792
Published: 2005
Journal Articles

Targeting the Insulin-Like Growth Factor-I Receptor (IGF-IR) in Multiple Myeloma Cells Using Selective IGF-IR Tyrosine Kinase Inhibitors.

Thomas Stromberg, PhD, Simon Ekman, MD, PhD, Leonard Girnita, PhD, Johan Lennartsson, Ulf Hellman, PhD, Kristina Carlson, MD, PhD, Anders Osterborg, MD, PhD, Karin Vanderkerken, PhD, Magnus Axelson, MD, PhD, Olle Larsson, MD, PhD, Kenneth Nilsson, MD, PhD, Helena Jernberg-Wiklund, PhD
Journal: Blood
Blood (2004) 104 (11): 639.
https://doi.org/10.1182/blood.V104.11.639.639
Published: 2004